In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Genomic Valley Biotech has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, the 10th August, 2021 at 11.45 am to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30th June, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the company has informed that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 1st July, 2021 till 48 hours of declaration of results 12th August, 2021.
The above information is a part of company’s filings submitted to BSE.